rs375253473
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_000260.4(MYO7A):c.2308G>A(p.Ala770Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000134 in 1,608,702 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_000260.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MYO7A | NM_000260.4 | c.2308G>A | p.Ala770Thr | missense_variant | 20/49 | ENST00000409709.9 | NP_000251.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MYO7A | ENST00000409709.9 | c.2308G>A | p.Ala770Thr | missense_variant | 20/49 | 1 | NM_000260.4 | ENSP00000386331 |
Frequencies
GnomAD3 genomes AF: 0.0000723 AC: 11AN: 152244Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000108 AC: 26AN: 241424Hom.: 0 AF XY: 0.000114 AC XY: 15AN XY: 131410
GnomAD4 exome AF: 0.000140 AC: 204AN: 1456458Hom.: 0 Cov.: 30 AF XY: 0.000145 AC XY: 105AN XY: 723988
GnomAD4 genome AF: 0.0000723 AC: 11AN: 152244Hom.: 0 Cov.: 33 AF XY: 0.0000807 AC XY: 6AN XY: 74370
ClinVar
Submissions by phenotype
not provided Uncertain:3Benign:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Jul 29, 2022 | Identified with additional MYO7A variants in a patient with mild adult-onset hearing loss in published literature (Ji et al., 2014); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 25342930) - |
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 28, 2024 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Mar 30, 2022 | The p.Ala770Thr variant in MYO7A has been reported in 1 Asian individual with adult-onset hearing loss (Ji 2014 PMID: 25342930) and has been identified by our laboratory in 1 Asian individual with features of Usher syndrome who carried pathogenic variants in another gene that were sufficient to explain their disease (LMM data). It has also been identified in 0.06% (11/19272) of East Asian chromosomes by gnomAD (http://gnomad.broadinstitute.org). However, this frequency is low enough to be consistent with a recessive allele frequency. This variant has also been reported in ClinVar (Variation ID 229002). Computational prediction tools and conservation analyses do not provide strong support for or against an impact to the protein. In summary, while the clinical significance of this variant is uncertain, these data suggest that it is more likely to be benign. ACMG/AMP Criteria applied: BP5. - |
Uncertain significance, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Jan 23, 2018 | The p.Ala770Thr variant (rs375253473) has not been reported in the medical literature; however a similar nearby variant (p.Ala771Ser) has been reported in two patients with Usher type I syndrome, one of whom carried a second PCDH15 variant (Nakanishi 2010 and Yoshimura 2014). This variant is listed in the Genome Aggregation Database (gnomAD) with a frequency of 0.05 percent in the East Asian population (identified on 10 out of 18,616 chromosomes), and has been reported to the ClinVar database with an uncertain classification (Variation ID: 229002). The alanine at position 770 is moderately conserved considering 13 species and computational analyses of the effects of the p.Ala770Thr variant on protein structure and function provide conflicting results (SIFT: damaging, MutationTaster: polymorphism, PolyPhen-2: possibly damaging). Altogether, there is not enough evidence to classify the p.Ala770Thr variant with certainty. - |
Usher syndrome type 1B Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | Natera, Inc. | Feb 02, 2020 | - - |
Usher syndrome type 1;C1832475:Autosomal dominant nonsyndromic hearing loss 11;C1838701:Autosomal recessive nonsyndromic hearing loss 2 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Dec 30, 2021 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at